Cargando…
IL4‐10 fusion protein: a novel immunoregulatory drug combining activities of interleukin 4 and interleukin 10
The objective of this study was to test the capacity of a newly developed fusion protein of interleukin 4 (IL‐4) and IL‐10 [IL4‐10 fusion protein (FP)] to shift multiple pro‐inflammatory pathways towards immune regulation, and to inhibit pro‐inflammatory activity in arthritis models. The effects of...
Autores principales: | Steen‐Louws, C., Hartgring, S. A. Y., Popov‐Celeketic, J., Lopes, A. P., de Smet, M. B. M., Eijkelkamp, N., Lafeber, F. P. J. G., Hack, C. E., van Roon, J. A. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300648/ https://www.ncbi.nlm.nih.gov/pubmed/30307604 http://dx.doi.org/10.1111/cei.13224 |
Ejemplares similares
-
Sialic Acid-Engineered IL4–10 Fusion Protein is Bioactive and Rapidly Cleared from the Circulation
por: Steen-Louws, Cristine, et al.
Publicado: (2019) -
The Role of Interleukin-4 and Interleukin-10 in Osteoarthritic Joint
Disease: A Systematic Narrative Review
por: van Helvoort, E.M., et al.
Publicado: (2022) -
Canine IL4-10 fusion protein provides disease modifying activity in a canine model of OA; an exploratory study
por: van Helvoort, E. M., et al.
Publicado: (2019) -
Immunoregulatory role of interleukin 10 in rheumatoid arthritis
Publicado: (1994) -
IL4-10 Fusion Protein Shows DMOAD Activity in a Rat Osteoarthritis
Model
por: van Helvoort, E.M., et al.
Publicado: (2021)